Print page   Email page   Download PDF
« Previous Release | Next Release »

Threshold Pharmaceuticals to Present at the Oppenheimer Healthcare Conference

SOUTH SAN FRANCISCO, CA -- (MARKET WIRE) -- 11/29/11 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that Dr. Barry Selick, Threshold's Chief Executive Officer, is scheduled to present at the 2011 Oppenheimer 22nd Annual Healthcare Conference in New York City on Tuesday, December 13, 2011 at 9:55AM EST.

A live webcast of the presentation will be available under the Webcast section of the Company's Website at www.thresholdpharm.com

About Threshold Pharmaceuticals

Threshold is a biotechnology company focused on the discovery and development of drugs targeting Tumor Hypoxia, the low oxygen condition found in microenvironments of most solid tumors as well as the bone marrows of some hematologic malignancies. This approach offers broad potential to treat a variety of cancers. By selectively targeting tumor cells, we are building a pipeline of drugs that hold promise to be more effective and less toxic to healthy tissues than conventional anticancer drugs. For additional information, please visit our website (www.thresholdpharm.com).

Contact:

Joel A. Fernandes

Threshold Pharmaceuticals, Inc.

650.474.8273

IR@thresholdpharm.com

Source: Threshold Pharmaceuticals

News Provided by Acquire Media

Close window | Back to top